Skip to main content
. 2019 Sep 25;11:1758835919877729. doi: 10.1177/1758835919877729

Figure 2.

Figure 2.

ROC curves for the cut-off points for the GTVnd (>20 ml versus ⩽20 ml) and pre-EBV DNA (>2000 copies/ml versus ⩽ 2000 copies/ml) and the integrated model for all NPC patients (n = 1500).

*Compared with the integrated model.

GTVnd, gross tumor volume of lymph nodes; pre-EBV, pretreatment plasma Epstein–Barr virus DNA; ROC, receiver operator characteristic.